Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2025 21.70M
June 30, 2025
March 31, 2025
December 31, 2024
September 30, 2024 2.011M
June 30, 2024 3.427M
March 31, 2024 4.45M
December 31, 2023 19.25M
September 30, 2023 28.92M
June 30, 2023 28.81M
March 31, 2023 26.36M
December 31, 2022 42.38M
September 30, 2022 38.72M
June 30, 2022 27.86M
March 31, 2022 29.23M
December 31, 2021 24.24M
September 30, 2021 24.86M
June 30, 2021 26.68M
March 31, 2021 27.26M
December 31, 2020 22.93M
September 30, 2020 26.49M
June 30, 2020 27.64M
March 31, 2020 27.53M
December 31, 2019 25.59M
September 30, 2019 25.22M
Date Value
June 30, 2019 25.46M
March 31, 2019 25.16M
December 31, 2018 0.397M
September 30, 2018 0.293M
June 30, 2018 0.357M
March 31, 2018 0.384M
December 31, 2017 2.375M
September 30, 2017 0.427M
June 30, 2017 0.3738M
March 31, 2017 0.3094M
December 31, 2016 0.1312M
September 30, 2016 0.0768M
June 30, 2016 1.048M
March 31, 2016 0.2997M
December 31, 2015 0.0813M
September 30, 2015 0.1759M
June 30, 2015 0.628M
March 31, 2015 0.6206M
December 31, 2014 1.016M
September 30, 2014 0.5829M
June 30, 2014 0.4964M
March 31, 2014 0.192M
December 31, 2013 0.0944M
September 30, 2013 0.0997M
June 30, 2013 0.1701M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 378.54M
Amgen, Inc. 83.95B
Anika Therapeutics, Inc. 46.19M
BioCryst Pharmaceuticals, Inc. 1.012B
Compugen Ltd. 49.63M